Cassey D. Bauer

Array ( [id] => 9408046 [patent_doc_number] => 20140099298 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-04-10 [patent_title] => 'Botulinum toxin treatments of Depression' [patent_app_type] => utility [patent_app_number] => 14/086086 [patent_app_country] => US [patent_app_date] => 2013-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 13099 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14086086 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10406981 [patent_doc_number] => 20150291991 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-10-15 [patent_title] => 'METHODS AND COMPOSITIONS RELATING TO AMYLOIDOGENIC POLYPEPTIDES' [patent_app_type] => utility [patent_app_number] => 14/441925 [patent_app_country] => US [patent_app_date] => 2013-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 26564 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14441925 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10399786 [patent_doc_number] => 20150284795 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-10-08 [patent_title] => 'Method for determining age independently of sex' [patent_app_type] => utility [patent_app_number] => 14/439639 [patent_app_country] => US [patent_app_date] => 2013-11-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5205 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14439639 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9305968 [patent_doc_number] => 20140044642 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-02-13 [patent_title] => 'RADIOPHARMACEUTICAL IMAGING OF NEURODEGENERATIVE DISEASES' [patent_app_type] => utility [patent_app_number] => 14/053382 [patent_app_country] => US [patent_app_date] => 2013-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 8703 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14053382 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10737561 [patent_doc_number] => 20160083712 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-03-24 [patent_title] => 'CSN5 POLYPEPTIDES AND USES THEREOF FOR SCREENING THERAPEUTIC AGENTS' [patent_app_type] => utility [patent_app_number] => 14/435375 [patent_app_country] => US [patent_app_date] => 2013-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11206 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14435375 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11698825 [patent_doc_number] => 09688728 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-06-27 [patent_title] => 'Bacteriophage gene 3 protein compositions and use as amyloid binding agents' [patent_app_type] => utility [patent_app_number] => 14/432861 [patent_app_country] => US [patent_app_date] => 2013-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 73 [patent_figures_cnt] => 90 [patent_no_of_words] => 31985 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 292 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14432861 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10399423 [patent_doc_number] => 20150284432 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-10-08 [patent_title] => 'PEPTIDES THAT BIND TO AMINO-TRUNCATED AMYLOID-BETA-PEPTIDE AND USE OF SAID PEPTIDES' [patent_app_type] => utility [patent_app_number] => 14/439895 [patent_app_country] => US [patent_app_date] => 2013-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 2746 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14439895 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10422540 [patent_doc_number] => 20150307552 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-10-29 [patent_title] => 'NOVEL D-ENANTIOMERIC PEPTIDES DERIVED FROM D3 AND USE THEREOF' [patent_app_type] => utility [patent_app_number] => 14/426797 [patent_app_country] => US [patent_app_date] => 2013-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5112 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14426797 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12212148 [patent_doc_number] => 09908943 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-03-06 [patent_title] => 'Single domain antibodies capable of modulating BACE activity' [patent_app_type] => utility [patent_app_number] => 14/023586 [patent_app_country] => US [patent_app_date] => 2013-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 11 [patent_no_of_words] => 18611 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14023586 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12212148 [patent_doc_number] => 09908943 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-03-06 [patent_title] => 'Single domain antibodies capable of modulating BACE activity' [patent_app_type] => utility [patent_app_number] => 14/023586 [patent_app_country] => US [patent_app_date] => 2013-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 11 [patent_no_of_words] => 18611 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14023586 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17680990 [patent_doc_number] => 11365229 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-06-21 [patent_title] => Methods of treating neurological diseases [patent_app_type] => utility [patent_app_number] => 14/427279 [patent_app_country] => US [patent_app_date] => 2013-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 11 [patent_no_of_words] => 21383 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14427279 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11463851 [patent_doc_number] => 09580469 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-02-28 [patent_title] => 'Peptides for the treatment and early diagnosis of Alzheimer\'s disease and other tauopathies' [patent_app_type] => utility [patent_app_number] => 14/432802 [patent_app_country] => US [patent_app_date] => 2013-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4180 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14432802 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10324437 [patent_doc_number] => 20150209442 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-07-30 [patent_title] => 'METHOD TO IMPROVE PHARMACOKINETICS OF DRUGS' [patent_app_type] => utility [patent_app_number] => 14/425105 [patent_app_country] => US [patent_app_date] => 2013-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6487 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14425105 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10326984 [patent_doc_number] => 20150211988 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-07-30 [patent_title] => 'RAMAN, INFRARED, OR RAMAN-INFRARED ANALYSIS OF PERIPHERAL BLOOD PLASMA PROTEIN STRUCTURE AND ITS RELATION TO COGNITIVE DEVELOPMENT IN ALZHEIMER\'S DISEASE' [patent_app_type] => utility [patent_app_number] => 14/423054 [patent_app_country] => US [patent_app_date] => 2013-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 24143 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14423054 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10292224 [patent_doc_number] => 20150177223 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-06-25 [patent_title] => 'System and Method for Detecting and Diagnosing Schizophrenia and Depression' [patent_app_type] => utility [patent_app_number] => 14/416842 [patent_app_country] => US [patent_app_date] => 2013-07-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7136 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14416842 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9222925 [patent_doc_number] => 20140017699 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-01-16 [patent_title] => 'ALZHEIMER\'S DISEASE ASSAY IN A LIVING PATIENT' [patent_app_type] => utility [patent_app_number] => 13/945612 [patent_app_country] => US [patent_app_date] => 2013-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 49 [patent_figures_cnt] => 49 [patent_no_of_words] => 56113 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13945612 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9191523 [patent_doc_number] => 20130330837 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-12-12 [patent_title] => 'MONOCLONAL ANTIBODIES THAT TARGET PATHOLOGICAL ASSEMBLIES OF AMYLOID BETA (ABETA)' [patent_app_type] => utility [patent_app_number] => 13/943031 [patent_app_country] => US [patent_app_date] => 2013-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 13325 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13943031 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9222923 [patent_doc_number] => 20140017698 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-01-16 [patent_title] => 'ALZHEIMER\'S DISEASE ASSAY IN A LIVING PATIENT' [patent_app_type] => utility [patent_app_number] => 13/942326 [patent_app_country] => US [patent_app_date] => 2013-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 49 [patent_figures_cnt] => 49 [patent_no_of_words] => 55954 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13942326 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10869811 [patent_doc_number] => 08895003 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-11-25 [patent_title] => 'Pharmaceutical composition comprising EDA-1 Fusion Protein' [patent_app_type] => utility [patent_app_number] => 13/922897 [patent_app_country] => US [patent_app_date] => 2013-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 29 [patent_no_of_words] => 12774 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 142 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13922897 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10468614 [patent_doc_number] => 20150353631 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-12-10 [patent_title] => 'C-TERMINAL AND CENTRAL EPITOPE A-BETA ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 14/410018 [patent_app_country] => US [patent_app_date] => 2013-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 23453 [patent_no_of_claims] => 116 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14410018 [rel_patent_id] =>[rel_patent_doc_number] =>)